New drug to treat chronic kidney disease gets approval Subject: Science and tech Section: Health Context: The Central Drugs Standard Control Organisation (CDSCO) has approved Jardiance (empagliflozin) 10mg tablets for end-stage kidney and  cardiovascular diseases. More on news: It will reduce the risk of sustained decline in patients with end-stage kidney disease, cardiovascular […]